We were selected to participate In the Blue Cross Blue Shield of Illinois early-stage accelerator program!

Written By Matthew Tabakin, MD

We are excited to announce that we have been selected to the BCBSIL to BCBSIL's inaugural Innovation Accelerator Program with MATTER. This is a fantastic opportunity for us to accelerate the growth of our startup, become a leader in the medication management space, and make a significant impact on quality of life and health outcomes.

Read the full article by clicking here! 

Matthew Tabakin, MD
Previous

Accelerating Innovation: Helping Patients and Caregivers Follow Doctors' Orders on Prescription Drugs